statistiche ricercatore

Continente	#
NA - Nord America	990
EU - Europa	300
AS - Asia	289
SA - Sud America	65
AF - Africa	35
Continente sconosciuto - Info sul continente non disponibili	22
OC - Oceania	1
Totale	1.702

Nazione	#
US - Stati Uniti d'America	974
SG - Singapore	107
VN - Vietnam	64
CN - Cina	58
IT - Italia	56
RU - Federazione Russa	53
BR - Brasile	49
DE - Germania	40
SE - Svezia	34
IE - Irlanda	27
HK - Hong Kong	25
GB - Regno Unito	24
CI - Costa d'Avorio	22
FR - Francia	18
FI - Finlandia	16
UA - Ucraina	13
CA - Canada	8
IN - India	8
AR - Argentina	7
MX - Messico	6
BD - Bangladesh	5
MA - Marocco	5
PL - Polonia	5
ZA - Sudafrica	5
ES - Italia	4
IQ - Iraq	4
JP - Giappone	4
EC - Ecuador	3
CL - Cile	2
CO - Colombia	2
DK - Danimarca	2
KR - Corea	2
PK - Pakistan	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
EG - Egitto	1
GP - Guadalupe	1
ID - Indonesia	1
KE - Kenya	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LV - Lettonia	1
MD - Moldavia	1
NL - Olanda	1
NO - Norvegia	1
OM - Oman	1
PY - Paraguay	1
RS - Serbia	1
SA - Arabia Saudita	1
TH - Thailandia	1
TN - Tunisia	1
TR - Turchia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.681

Nome	#
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis	261
Long‑responders to anti‑HER2 therapies: A case report and review of the literature	178
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients	175
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic	172
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience	170
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going?	168
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study	150
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC	147
Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase	141
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience	140
Totale	1.702

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	78	0	0	0	1	3	15	7	4	14	7	9	18
2022/2023	272	19	25	15	23	10	101	0	9	44	1	18	7
2023/2024	119	21	2	8	4	17	42	2	4	0	1	0	18
2024/2025	251	41	20	11	4	8	13	20	18	35	14	32	35
2025/2026	645	64	29	32	71	80	55	98	64	53	61	10	28
2026/2027	122	6	71	15	30	0	0	0	0	0	0	0	0
Totale													1.702